IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Onyx Pharmaceuticals Inc

CUSIP: 683399959 | 8 institutional holders

Quarters

Q3 2013Q2 2013
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile